DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

47 hedge funds and large institutions have $201M invested in Dicerna Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.

Holders
47
Holders Change
+7
Holders Change %
+17.5%
% of All Funds
1.25%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
17
Increased
14
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$25M
2
CAM
2
Cormorant Asset Management
Massachusetts
$3.29M
3
SFM
3
Sphera Funds Management
Israel
$2.91M
4
TCM
4
Tekla Capital Management
Massachusetts
$2.57M
5
USAA
5
United Services Automobile Association
Texas
$782K

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
BCPEM
2
Bain Capital Public Equity Management
Massachusetts
$0
3
OM
3
Opaleye Management
Massachusetts
$0
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$0
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$5M
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
51
SSI Investment Management
California
– -$192K -15,110 Closed
CS
52
Credit Suisse
Switzerland
– -$159K -12,536 Closed
SSG
53
Summit Securities Group
New York
– -$67K -5,263 Closed
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
– -$2.13K -167 Closed
1 2
3